Zytiga? 90-yttrium (Y) ibritumomab tiuxetan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zytiga? 90-yttrium (Y) ibritumomab tiuxetan, covering 2018-05-14 to 2018-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma [Phase 2]